Replies to post #15999 on Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

FBG - You raise a good question, why are shorts targeting Advaxis? But the another question may be just as important. Who is targeting Advaxis? This assumes, of course, that shorts come in different flavors. A "pure" short, so to speak, may target Advaxis for the reason you state - that is they don't believe mgt can overcome their shorting and the company will go belly up despite the science. But no one on this board believes the science is bad (why invest, or stay invested, if you don't believe in it?). Indeed, the science proves itself over and over and over. All who have done even a modicum of due diligence knows that by now.
But what if it's not a pure short that is shorting? What if it's someone with a more determined agenda? What if it's someone, or some company or companies more specifically, that have a lot to lose if Advaxis actually is successful? As you can see, I have my tinfoil hat on right now, but bear with me. Could it be that a consortium of BP is shorting because they don't want the disruption in the market a successful Advaxis may bring? Will Advaxis be a disruptor in the market if successful? I keep reminding people here that the cost to produce a dose is under the cost of about 2 cups of coffee - that sounds disruptive to me, though what they charge for the vaccine will be a whole other matter.
That's one possibility. Here's another: What if some company knows Advaxis will be successful? What if this company is trying to accumulate shares at this reduced sp? I know you remember the flash crash in the sp awhile ago. Tell me that wasn't orchestrated. I freely admit I'm not knowledgeable enough to comment further on this but others here are so I invite them to put in their 2 cents.
So I suggest there are at least three types of shorts:
1 - Pure shorts
2 - Shorts that don't wan't Advaxis to succeed because it will damage them somehow.
3 - Shorts that know Advaxis will succeed and want a piece of the pie.

Are there other types? Feel free to speculate, as I've said, I have my tin foil hat on!!

[raja48185]

fbg

I have been saying all along - management has taken us from 'one time leaders' in immunotherapy to hopeless laggards as they grope in the dark and fail to establish priorities. I have no doubts about the science at all.


We should have had a completed Phase III by now and probably a FDA approved drug, but for the misplaced priorities. Management has enriched themselves with shares and stock options. After a reverse split this stock is still, after so many years, less than real value of 8 cents (before split).

Money they have raised thus far will be gone before long and then we will have another capital raise - for what? NOTHING!!

[blueyedcatch]

Same reason they targeted most of the small cap spec Bio`s,drug price talk on top of a 2 year bio bear market..C`mon,you`re talking to me..

[Easymoneyman00]

Fbg, I believe most don't believe our Lm therapy is the real deal. Only one other Lm technology threrapy besides us and they have a failed trial already? It's a tough business not everyone sold yet but some are betting on us to have the majic vaccine!